Clinical Trials Directory

Trials / Completed

CompletedNCT01952626

Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Kyungpook National University Hospital · Academic / Other
Sex
All
Age
19 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Intrathecal administration of morphine is often used for control of postoperative pain. However, pruritus is one of the most common side effects of intrathecal morphine . Specific serotonin receptor antagonists could be an effective prophylactic treatment of neuraxial opioid-induced pruritus. It was reported that palonosetron is more effective than ondansetron for prevention of postoperative nausea and vomiting. Therefore, the investigators evaluated the efficacy of prophylactic administration of ondansetron and palonosetron for the prevention of intrathecal morphine-induced pruritus.

Detailed description

Intrathecal administration of morphine is often used for relief of postoperative pain. However, pruritus is one of the most common side effects associated with intrathecal morphine. Specific serotonin receptor antagonists such as ondansetron could be an effective prophylactic treatment of neuraxial opioid-induced pruritus. It was reported that palonosetron is more effective than ondansetron for prevention of postoperative nausea and vomiting. Therefore, the investigators evaluated the efficacy of prophylactic administration of ondansetron and palonosetron for the prevention of intrathecal morphine-induced pruritus.

Conditions

Interventions

TypeNameDescription
DRUGOndansetronintravenous injection
DRUGPalonosetronintravenous injection

Timeline

Start date
2013-04-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2013-09-30
Last updated
2015-04-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01952626. Inclusion in this directory is not an endorsement.